Details for 2011772834
Up to date per 05.04.2026
Actions
Details for 2011772834
Granted/Registered
European Patent
27.02.2013 A
08.03.2017 B1
13.01.2011
US
432372 P
29.10.2010
US
456014 P
09.09.2010
US
403011 P
26.05.2010
US
396376 P
23.04.2010
US
343177 P
A61K 38/46 20060101AFI20140218BHEP
Owner
Alexion Pharmaceuticals, Inc.100 College Street New Haven, CT 06510US
Representative
Representative
Kliment & Henhapel Patentanwälte OGGonzagagasse 151010 WienAT
Inventor
QUINN, Anthony107 Manet Road Chestnut Hill Massachusetts 02467US
HARVEY, Alex J.106 Fox Trace Athens Georgia 30606US
Information about Fees